biosimilars
Celltrion acquires US biopharma plant from Eli Lilly to counter tariff threats
S. Korea aims to double bio exports by 2030 to enter global top 5
Indian pharma market up by 7.9pc in July, cardiac & anti-diabetes therapies show strong volume
Dr. Reddy's Laboratories' net profit slumps 11 pc to Rs 14,09 crore sequentially in Q1